Cargando…

Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19

1 year after an acute COVID-19 episode, patients with either lung sequelae or long COVID show a stronger SARS-CoV-2-specific T-cell response than fully recovered individuals, suggesting persistent cell stimulation by residual viral reservoirs https://bit.ly/40bPZm7

Detalles Bibliográficos
Autores principales:	Cruz, Tamara, Mendoza, Núria, Lledó, Gema M., Perea, Lídia, Albacar, Núria, Agustí, Alvar, Sellares, Jacobo, Sibila, Oriol, Faner, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204814/ https://www.ncbi.nlm.nih.gov/pubmed/37228290 http://dx.doi.org/10.1183/23120541.00020-2023

Ejemplares similares

SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae
por: Cruz, Tamara, et al.
Publicado: (2022)

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge
por: Sibila, Oriol, et al.
Publicado: (2022)

Lung Function sequelae in COVID-19 Patients 3 Months After Hospital Discharge
por: Sibila, Oriol, et al.
Publicado: (2021)

Molecular Interactions of SARS-CoV-2 in Lung Tissue of Patients with Chronic Obstructive Pulmonary Disease
por: Agusti, Alvar, et al.
Publicado: (2021)

COVID-19 and lung involvement
por: You, Jin-Seok, et al.
Publicado: (2022)

Blood Immunophenotypes of Idiopathic Pulmonary Fibrosis: Relationship with Disease Severity and Progression
por: Mendoza, Nuria, et al.
Publicado: (2023)

[Translated article] Histology Study of Postmortem Lung Biopsies in Patients With Covid-19 Pneumonia
por: Sellarés, Jacobo, et al.
Publicado: (2022)

Estudio histológico mediante biopsia pulmonar post mortem en pacientes con neumonía por COVID-19
por: Sellarés, Jacobo, et al.
Publicado: (2022)

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?
por: Halpin, David M G, et al.
Publicado: (2020)

Systemic Inflammatory Response to Smoking in Chronic Obstructive Pulmonary Disease: Evidence of a Gender Effect
por: Faner, Rosa, et al.
Publicado: (2014)

Lung immune signatures define two groups of end-stage IPF patients
por: Cruz, Tamara, et al.
Publicado: (2023)

Cellular Senescence in Lung Fibrosis
por: Hernandez-Gonzalez, Fernanda, et al.
Publicado: (2021)

Liver epigenome changes in patients with hepatopulmonary syndrome: A pilot study
por: Mendoza, Nuria, et al.
Publicado: (2021)

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19
por: Agusti, Alvar, et al.
Publicado: (2021)

When Harry Met Sally, or When Machine Learning Met Chronic Obstructive Pulmonary Disease
por: Agusti, Alvar, et al.
Publicado: (2020)

From systems biology to P4 medicine: applications in respiratory medicine
por: Noell, Guillaume, et al.
Publicado: (2018)

Reduced airway levels of fatty-acid binding protein 4 in COPD: relationship with airway infection and disease severity
por: Perea, Lídia, et al.
Publicado: (2020)

Low birth weight as a potential risk factor for severe COVID-19 in adults
por: Crispi, Fàtima, et al.
Publicado: (2021)

Inhaled corticosteroids for the treatment of COVID-19
por: Bafadhel, Mona, et al.
Publicado: (2022)

Validity of prognostic models of critical COVID-19 is variable. A systematic review with external validation
por: Cárdenas-Fuentes, Gabriela, et al.
Publicado: (2023)

Reply to Guo et al.
por: Wang, Gang, et al.
Publicado: (2023)

Improving home oxygen therapy in patients with interstitial lung diseases: application of a noninvasive ventilation device
por: Cuerpo, Sandra, et al.
Publicado: (2020)

Towards a global initiative for fibrosis treatment (GIFT)
por: Molina-Molina, Maria, et al.
Publicado: (2017)

Telomere Length but Not Mitochondrial DNA Copy Number Is Altered in Both Young and Old COPD
por: Casas-Recasens, Sandra, et al.
Publicado: (2021)

From Silicosis to Scleroderma: Erasmus Syndrome
por: Noboa, María Belén, et al.
Publicado: (2023)

Characterization, localization and comparison of c-Kit+ lung cells in never smokers and smokers with and without COPD
por: López-Giraldo, Alejandra, et al.
Publicado: (2018)

Human senescent fibroblasts trigger progressive lung fibrosis in mice
por: Hernandez-Gonzalez, Fernanda, et al.
Publicado: (2023)

Structural brain changes in post‐acute COVID‐19 patients with persistent olfactory dysfunction
por: Campabadal, Anna, et al.
Publicado: (2022)

Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD)
por: Cruz, Tamara, et al.
Publicado: (2019)

Acute exacerbations of idiopathic pulmonary fibrosis: Does clinical stratification or steroid treatment matter?
por: Cuerpo, Sandra, et al.
Publicado: (2019)

Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition
por: Lledó, Gema M., et al.
Publicado: (2022)

Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial
por: Agustí, Alvar, et al.
Publicado: (2022)

Bone marrow characterization in COPD: a multi-level network analysis
por: Toledo-Pons, Nuria, et al.
Publicado: (2018)

An investigation of the resolution of inflammation (catabasis) in COPD
por: Noguera, Aina, et al.
Publicado: (2012)

Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry
por: Cortellini, Alessio, et al.
Publicado: (2022)

Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients
por: Millares, Laura, et al.
Publicado: (2019)

COVID-19 diagnostic tests: Importance of the clinical context()
por: Vila Muntadas, Marc, et al.
Publicado: (2021)

Pruebas diagnósticas COVID-19: importancia del contexto clínico
por: Vila Muntadas, Marc, et al.
Publicado: (2021)

The pathophysiology of postacute sequelae of COVID-19 (PASC): Possible role for persistent inflammation
por: Marshall, Gailen D.
Publicado: (2023)

Exploring risk factors for persistent neurocognitive sequelae after hospitalization for COVID‐19
por: Ch'en, Peter Y., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_heuui02b1v9si95vmka85im8kf